These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19447649)

  • 1. Coronary stents and antiplatelet therapy: patients' and health professionals' understanding of the implications.
    Bauer WO; Ng L; Jones C; O'Riordan J
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):383-4. PubMed ID: 19447649
    [No Abstract]   [Full Text] [Related]  

  • 2. The patient with coronary stents and antiplatelet agents: what to do and how to deal?
    Bornemann H; Prüller F; Metzler H
    Eur J Anaesthesiol; 2010 May; 27(5):406-10. PubMed ID: 20009935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents: patient understanding of the risks of premature cessation of antiplatelet drugs.
    Trentman TL; Rosenfeld DM; Danielson DR; Hagstrom SG
    J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):806-10. PubMed ID: 18834797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
    Gurbel PA; DiChiara J; Tantry US
    Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
    Sharma A; Berkeley A
    J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 12. Bare-metal versus drug-eluting coronary stents.
    Agostoni P; Vermeersch P
    N Engl J Med; 2008 Jun; 358(23):2516-7; author reply 2517-8. PubMed ID: 18536096
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document.
    Guagliumi G; Musumeci G; Rossini R; Bolognese L; Giordano A; Marzocchi A; Ramondo A; Sangiorgi G; Tamburino C; Tomai F; De Servi S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):782-91. PubMed ID: 17885515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents and antiplatelet resistance.
    Simon DI; Jozic J
    Am J Cardiol; 2008 Nov; 102(9 Suppl):29J-37J. PubMed ID: 18928790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
    Xue F; Yang XJ; Cheng XJ; Hui J; Jiang TB; Chen T; Liu ZH; Song JP; Jiang WP
    Chin Med J (Engl); 2009 Oct; 122(19):2394-5. PubMed ID: 20079146
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stent pathology--should we still be cautious?
    Nakazawa G; Finn AV; Virmani R
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):1. PubMed ID: 18094669
    [No Abstract]   [Full Text] [Related]  

  • 19. Late coronary stent thrombosis complicating urologic surgery.
    de Korte FI; van Werkum JW; Vijverberg PL; Ten Berg JM
    Eur Urol; 2008 Jul; 54(1):221-5; quiz 225. PubMed ID: 17964710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.